US Patent Issued to GALECTO BIOTECH on Oct. 27 for "Amorphous form of 5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1H-1,2,3-triazol-1-yl-1-thio-alpha-d-galactopyranoside" (Danish, British Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,298, issued on Oct. 27, was assigned to GALECTO BIOTECH AB (Copenhagen, Denmark).

"Amorphous form of 5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1H-1,2,3-triazol-1-yl-1-thio-alpha-d-galactopyranoside" was invented by Lise Gravelle (Copenhagen, Denmark), Peter Timmins (Cheshire, Great Britain) and Anders Pedersen (Copenhagen, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "A stabilized amorphous form of a compound of formula I as well as compositions for oral administration including the compound of formula I in a therapeutically effective amount. Also, methods for treatment of a disease or disorder in which therapeutically effect...